• Sinohealth Technology remains noncompliant with Hong Kong listing Rule 13.32B, with public shareholders holding 15.46% of its issued shares.
• Restoration plans include equity financing or major shareholder sales to independent investors, targeting a public float increase of at least 8 percentage points.
• The company targets compliance with the initial prescribed public float threshold by the end of June 2027.
• Share award grants to non-core connected persons would cover at least 2% of total share capital annually in 2026, 2027 and 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinohealth Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261105-12401654), on November 05, 2026, and is solely responsible for the information contained therein.